Catalyst Wire Dossier Catalyst Wire Dossier

Verzenio (abemaciclib)

abemaciclib · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Verzenio (abemaciclib), covering 2018-03-13 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME) [NA]

See pricing